|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Picking up on the thread of my last editorial in the Summer issue of PMPS, it's painful to hear of the widespread shake-out going on throughout our industry. It seems that no organisation is so big that it can't get bigger through consolidation, without shedding layers of management or teams of skilled professionals, while none is so small that it lacks scope for becoming even leaner by downsizing. In the current climate of economic downturn, the bottom line is that accounts matter a great deal for the survival of businesses as the struggle continues to prune costs and aim for profitability.
Browsing the bumper crop of articles in the current and recent issues of PMPS, it appears that intellectual property (IP) has moved centre stage from the periphery of the
life science arena. In one corner are illegal counterfeiting practices, out to make a fast buck from pushing pirated versions of drugs by exploiting an unfulfilled consumer-driven demand (see page 109). In another there's a rising tide of products losing their patent protection and opening the way for cheaper generic versions, meeting the need for governments to contain costs (see page88). This leaves big pharma with the enormous task of replenishing its depleted development pipeline with innovative products from the biotech sector, while remaining saddled with the mounting costs of development. Overseeing this turf war is the regulatory gamekeeper barely able to keep up with the game (see page 72 on EU Clinical Trials Directive).
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee
Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >> |
|
 |
White Papers |
 |
|
Personalised Medicine - Pharma and Dx Firms Share Wider Horizons
DiagnostikNet-BB
Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >> |
|
 |
Industry Events |
 |
DIA 2019 Global Annual Meeting
23-27 June 2019, San Diego Convention Center
DIA 2019 is more than just a meeting: it’s where
brilliant minds come together to create solutions. Thousands of global
innovators will convene to engage in discussions on today’s hottest topics in
the life sciences field, propose ways to combat daily challenges, and network
to create lasting connections.
More info >> |
|
|
